Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

MDLN stock hub

Medline Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MDLNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

51.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MDLN

In the news

Latest news · MDLN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.8

P25 12.3P50 18.4P75 33.1

Trailing P/E34.6

P25 14.9P50 23.2P75 38.5

ROE6

P25 -105.6P50 -46.5P75 -3.1

ROIC6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MDLN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002046386
Company name	Medline Inc.
Country	United States
Country code	US
Cusip	58507V107
Employees	45,000
Employees Change	2,000%
Employees Change Percent	4.65
Enterprise value	$62.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2025-12-17
Isin	US58507V1070
Last refreshed	2026-05-10
Market cap	$51.9B
Market cap category	Large-Cap
Price	$39.52
Price currency	USD
Rev Per Employee	647,555.56x
Sector	Healthcare
Sic	3841
Symbol	MDLN
Website	https://www.medline.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.86%
EV Earnings	64.48x
EV Sales Forward	1.95x
EV/EBIT	30.74x
EV/EBITDA	20.46x
EV/FCF	62.54x
EV/Sales	2.14x
FCF yield	1.92%
Forward P/E	25.8x
P/B ratio	2.97x
P/E ratio	34.61x
P/S ratio	1.78x
PEG ratio	2.37x
PS Forward	1.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.95%
EBITDA Margin	10.45%
FCF margin	3.42%
Gross margin	25.86%
Gross Profit	$7.5B
Gross Profit Growth	5.89%
Gross Profit Growth Q	0.93%
Net Income	$966M
Net Income Growth	-21.37%
Net Income Growth Q	-59.94%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	4.12%
Profit Margin	3.32%
Profit Per Employee	$21,467
Profitable Years	1
ROCE	5.55
ROE	6.05
ROIC	6.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
FCF Growth	-34.13%
FCF Growth Q	-45.89%
OCF Growth	-22.05%
OCF Growth Q	-39.59%
Revenue Growth	12.15x
Revenue Growth Q	10.66x
Revenue Growth Quarters	2x
Revenue Growth Years	3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$39B
Cash	$2.3B
Current Assets	$11.2B
Current Liabilities	$2.5B
Debt	$12.6B
Debt EBITDA	$3.98
Debt Equity	$0.65
Debt FCF	$12.69
Equity	$19.3B
Interest Coverage	2.34
Liabilities	$19.7B
Long Term Assets	$27.8B
Long Term Liabilities	$17.1B
Net Cash	$-10.4B
Net Cash By Market Cap	$-19.97
Net Debt EBITDA	$3.41
Net Debt Equity	$0.54
Net Debt FCF	$10.41
Tangible Book Value	$-10.5B
Tangible Book Value Per Share	$-12.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.41
Net Working Capital	$6.5B
Quick ratio	2.34
Working Capital	$8.6B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	44.15
All Time High	50.88
All Time High Change	-22.32%
All Time High Date	2026-02-25
All Time Low	34.89
All Time Low Change	13.27%
All Time Low Date	2025-12-17
ATR	1.93
Beta1y	1.56
Ch YTD	-5.9
High	42.22
High52	50.88
High52 Date	2026-02-25
High52ch	-22.32%
Low	39.1
Low52	34.89
Low52 Date	2025-12-17
Low52ch	13.27%
Ma50ch	-10.48%
Premarket Change Percent	-0.05
Premarket Price	$41.84
Premarket Volume	627
RSI	31.84
RSI Monthly	0
RSI Weekly	44.38
Sharpe ratio	-0.13x
Sortino ratio	-0.04
Tr YTD	-5.9
Tr1m	-8.35%
Tr1w	-11.69%
Tr3m	-16.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	23
Analyst Count Top	4
Analyst Price Target Top	$52.75
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.29
Earnings Revenue Estimate	7,156,032,320x
Operating Income	$2B
Operating Income Growth	-6.2
Operating Income Growth Q	-27.72
Operating margin	6.95
Price target	$50.48
Price Target Change	$27.73
Price Target Change Top	$33.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	319,411,045%
Float Percent	24.31%
Net Borrowing	-4,128,000,000
Shares Insiders	1.11%
Shares Institutions	36.63%
Shares Out	1,313,688,164
Shares Qo Q	1.83%
Short Float	5.84%
Short Ratio	2.66
Short Shares	1.42

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$916M
Average Volume	6,158,494.65x
Bv Per Share	13.32
CAPEX	$-478M
Ch1m	-8.35
Ch1w	-11.69
Ch3m	-16.45
Change	-5.59%
Change From Open	-5.48
Close	41.86
Days Gap	-0.12
Depreciation Amortization	1,018,000,000
Dollar Volume	468,434,393.4
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$2B
EBITDA	$3B
EPS	$1.14
F Score	3
FCF	$996M
FCF EV Yield	1.6x
FCF Per Share	$0.76
Financing CF	395,000,000
Fiscal Year End	December
Founded	1,966
Goodwill	8,076,000,000
Graham Number	18.50162
Graham Upside	-53.18
Income Tax	$127M
Investing CF	-478,000,000
Ipr	36.28
Iprfo	12.91
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-28
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma20	45.32
Ma20ch	-12.79%
Net CF	1,398,000,000
Next Earnings Date	2026-11-18
Open	41.81
Optionable	Yes
P FCF Ratio	52.13
P OCF Ratio	35.22
Position In Range	13.46
Post Close	39.52
Postmarket Change Percent	1.22
Postmarket Price	$40
Ppne	4,758,000,000
Pre Close	41.86
Price Date	2026-05-08
Price EBITDA	$17.06
Relative Volume	1.92x
Revenue	29,140,000,000x
SBC By Revenue	0.27x
Share Based Comp	80,000,000
Tax By Revenue	0.44x
Tax Rate	10.57%
Us State	Illinois
Volume	11,853,097
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MDLN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MDLN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+36.6%

Float: +24.3% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MDLN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.8

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MDLN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MDLN stock rating?

Medline Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MDLN analysis?

The full report lives at /stocks/MDLN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MDLN?

The latest report frames MDLN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MDLN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.